Delays in cancer diagnosis: challenges and opportunities in Europe

Delays in cancer diagnosis: challenges and opportunities in Europe


  • Cristina Renzi
  • Stefano Odelli a:1:{s:5:"en_US";s:42:"Vita-Salute San Raffaele University, Milan";}
  • Federica Morani
  • Sara Benitez Majano
  • Carlo Signorelli


cancer, diagnosis, chronic disease, mental health, COVID-19, Italy, Europe


Background and aim: Early cancer diagnosis is a public health priority, but large proportions of patients are diagnosed with advanced disease or as an emergency, even in countries with universal healthcare coverage. The study aimed at examining factors contributing to diagnostic delays and inequalities in cancer care, discussing challenges and opportunities for improving the diagnosis of cancer. Methods: We performed a critical review of the literature examining factors contributing to delays and inequalities in cancer diagnosis, published between 2019-2023, in Europe with a specific focus on Italy. Results: Disparities in screening, cancer diagnosis and treatment have been reported in many European countries, with poorer outcomes for some population sub-groups. For example, some Northern regions in Italy have six-times higher screening participation versus Southern regions. In 2019 36% of the Italian population aged 50-74 reported colorectal cancer screening, higher than the EU average (33%), but lower than in countries like Denmark (>60%). In Italy, the EU country with the largest percentage of people aged 65+, incident cancers are expected to rise by 19.6% over two decades. Older age is also associated with multimorbidity, with physical and mental health morbidities possibly affecting cancer diagnostic pathways. For example, colon cancer patients with pre-existing mental health conditions were 28% less likely to have a prompt colonoscopy when presenting with red-flag symptoms, according to recent UK research. Covid-19 has exacerbated pre-existing inequalities, with reductions in scheduled surgery and oncological treatments, especially affecting women, older and less educated individuals. Conclusions: For ensuring appropriate care, it is crucial to better understand how different factors, including physical and mental health morbidities, impact cancer diagnosis. The “NextGenerationEU” program and the “National Recovery and Resilience Plan” (PNNR in Italy) following the Covid-19 pandemic offer opportunities for reducing inequalities, improving cancer care and chronic disease management for ageing populations.


Piano Oncologico Nazionale: documento di pianificazione e indirizzo per la prevenzione e il contrasto del cancro 2023-2027

NHS screening UK,

NICE guidelines UK,

ECIS - European Cancer Information System

The Lancet Regional Health - Europe 2022;21: 100458 Published online 6 July 2022

“Profili sul cancro per paese” European Cancer Inequalities Registry – Italy, OECD,

“It Can Be Done – Beating Inequalities in Cancer Care.” Action Report of the European Cancer Organisation; 10 November 2020

Rapporto annuale 2022, ISTAT (Italian National Institute of Statistics)

“I numeri del cancro in Italia 2022” Report AIOM 2022

Armaroli P, Battagello J, Battisti F, et al, ONS (osservatorio nazionale screening): Rapporto sui ritardi accumulati alla fine di maggio 2020 dai programmi di screening Italiani e sulla velocità della ripartenza.

Renzi C, Kaushal A, Emery J, et al. Comorbid chronic diseases and cancer diagnosis: disease-specific effects and underlying mechanisms. Nat Rev Clin Oncol. 2019;16(12):746-761. doi:10.1038/s41571-019-0249-6

Benitez Majano S, Lyratzopoulos G, de Wit NJ, et al. Mental Health Morbidities and Time to Cancer Diagnosis Among Adults With Colon Cancer in England. JAMA Netw Open. 2022;5(10):e2238569. Published 2022 Oct 3. doi:10.1001/jamanetworkopen.2022.38569

Solmi M, Firth J, Miola A, et al. Disparities in cancer screening in people with mental illness across the world versus the general population: prevalence and comparative meta-analysis including 4 717 839 people. Lancet Psychiatry. 2020 Jan;7(1):52-63. doi: 10.1016/S2215-0366(19)30414-6.

Davis LE, Bogner E, Coburn NG, et al. Stage at diagnosis and survival in patients with cancer and a pre-existing mental illness: a meta-analysis. J Epidemiol Community Health. 2020 Jan;74(1):84-94. doi: 10.1136/jech-2019-212311.

Di Girolamo C, Gnavi R, Landriscina T, et al. Indirect impact of the COVID-19 pandemic and its containment measures on social inequali-ties in hospital utilisation in Italy [published online ahead of print, 2022 May 12]. J Epidemiol Community Health. 2022;jech-2021-218452. doi:10.1136/jech-2021-218452

Ricciardiello L, Ferrari C, Cameletti M, et al. Impact of SARS-CoV-2 Pandemic on Colorectal Cancer Screening Delay: Effect on Stage Shift and Increased Mortality. Clin Gastroenterol Hepatol. 2021;19(7):1410-1417.e9. doi:10.1016/j.cgh.2020.09.008

Mentrasti G, Cantini L, Zichi C, et al. Alarming Drop in Early Stage Colorectal Cancer Diagnoses After COVID-19 Outbreak: A Real-World Analysis from the Italian COVID-DELAY Study. Oncologist. 2022;27(9):e723-e730. doi:10.1093/oncolo/oyac129

Rottoli M, Gori A, Pellino G, et al. Colorectal Cancer Stage at Diagnosis Before vs During the COVID-19 Pandemic in Italy. JAMA Netw Open. 2022;5(11):e2243119. doi: 10.1001/jamanetworkopen.2022.43119

Tarricone R, Listorti E, Tozzi V, et al. Transformation of Cancer Care during and after the COVID Pandemic, a point of no return. The Ex-perience of Italy. J Cancer Policy. 2021;29:100297. doi:10.1016/j.jcpo.2021.100297

Crispo A, Montagnese C, Perri F, et al. COVID-19 Emergency and Post-Emergency in Italian Cancer Patients: How Can Patients Be Assisted?. Front Oncol. 2020;10:1571. doi: 10.3389/fonc.2020.01571




How to Cite

Renzi C, Odelli S, Morani F, Benitez Majano S, Signorelli C. Delays in cancer diagnosis: challenges and opportunities in Europe. Acta Biomed [Internet]. 2023 Aug. 30 [cited 2024 Jul. 17];94(S3):e2023161. Available from: